Neuland Health Sciences Private Limited, a amalgamated private limited company, was established on 31 March 1993 in Hyderabad, Telangana, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U73100TG1993PTC015554. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹18.50 Cr and a paid-up capital of ₹12.43 Cr.
Employing 41 professional, Its leadership includes Ramamohan Davuluri Rao (Director), Saharsh Rao Davuluri (Director), Sucheth Rao Davuluri (Director). Past directors included Davuluri Vijaya Rao, Tirunelveli Padmanabhan Devarajan, Ramamohan Davuluri Rao. It holds no open charges and ₹153.40 Cr settled loans. Its latest AGM occurred on 28 December 2017, with the balance sheet filed on 31 March 2017. It is based at Sanali Info Park, 'A' Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills,, Hyderabad, Telangana, 500034.
U73100TG1993PTC015554
015554
31 March 1993
₹18.50 Cr
₹12.43 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Neuland Health Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramamohan Davuluri Rao | Director | 16 Apr 2012 | Current |
| Saharsh Rao Davuluri | Director | 14 Oct 1999 | Current |
| Sucheth Rao Davuluri | Director | 07 Mar 1997 | Current |
| Sumeet Nagar | Additional Director | 23 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Apr 2012 | Past |
| Pramod Abcsdd | Alternate Director | 22 Jun 2017 | Past |
| Pramod Abcsdd | Additional Director | 04 Jun 2012 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
| Pramod Abcsdd | Director | 22 Jun 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neuland Health Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 33.34% increase. The company also saw a substantial fall in profitability, with a 82.17% decrease in profit. The company's net worth dipped by a decrease of 6.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Neuland Health Sciences had a promoter holding of 64.11% and a public holding of 35.89%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,534,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2005 | State Bank Of India | ₹150.90 Cr | Satisfied |
| 29 Jan 2001 | Canbank Factors Limited | ₹2.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Neuland Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neuland Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Health Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Neuland Health Sciences Private Limited last Annual general meeting of members was held on 28 Dec 2017 as per latest MCA records. was documented.
The activity Sumeet Nagar was appointed as a Additional Director was appointed as a Additional Director on 23 Jun 2017 & has been associated with this company since 8 years 5 months . was completed.
Progress on Neuland Health Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was documented.
The activity A charge registered on 12 Jan 2005 via Charge ID 90136895 with State Bank Of India was fully satisfied on 11 Apr 2016. was completed.
Namita Afzulpurkar was appointed as a Company Secretary was appointed as a Company Secretary on 25 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 150.90 Cr registered on 12 Jan 2005 with Charge ID 90136895 was modified on 04 Sep 2013. was documented.
Neuland Laboratories Q2 FY24 results: Revenue increased by 42.23% YoY & profit increased by 132.06% YoY.
Mumbai companies Minda Corp., Neuland Laboratories, and Simplex Infrastructure raised Rs837.79 crore through QIP offerings. Minda Corp. sold shares at Rs173.47 per share, showing investors' confidence in their business. Neuland Laboratories and Simplex Infrastructure also successfully raised funds through QIP. QIP is a way for listed companies to sell equity shares to qualified institutional buyers. In 2018, 17 companies have raised Rs11,049.8 crore through QIPs. In 2017, 43 companies raised Rs56,152 crore, the highest since 2009..
The CIN of Neuland Health Sciences Private Limited is U73100TG1993PTC015554.
Neuland Health Sciences Private Limited is headquartered at Sanali Info Park, 'A' Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills,, Hyderabad, Telangana, 500034.
Neuland Health Sciences Private Limited was incorporated on 31 March 1993.
The current directors of Neuland Health Sciences Private Limited are
The primary industry of Neuland Health Sciences Private Limited is Pharma.
Neuland Health Sciences Private Limited is unlisted.
The authorized capital of Neuland Health Sciences Private Limited is ₹18.50 Cr, and the paid-up capital is ₹12.43 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX